Sequana Medical announces 2023 Full Year Results and 2024 Outlook

PRESS RELEASE

Related Keywords

Ukraine ,Machelen ,Region Flamande ,Belgium ,Boston ,Massachusetts ,United States ,Canada ,China ,United Kingdom ,British ,American ,Peter Dhondt ,Kenneth Macleod ,Cian Crosbie ,Company Premarket Approval ,Good Laboratory Practice ,Device Single Audit Program ,British Standards Institution ,American Consortium For The Study Of End ,Company Or Sequana ,Sequana Medical Us Inc ,American Medical Association ,Sequana Medical ,Euronext Brussels ,Chief Executive Officer ,Rosetta Capital ,Data Safety Monitoring Board ,Thousand Euros ,Loss Per Share ,Not Meaningful ,North American ,Investor Warrants ,Bootstrap Warrants ,Kreos Subscription Rights ,Middle East ,Executive Management ,Kreos Capital ,Annual Report ,Annual General Meeting ,Premarket Approval ,Pricewaterhousecoopers Bedrijfsrevisoren ,Peterd Hondt ,North American Consortium ,Investigational New ,Good Laboratory ,Medical Device Single Audit ,British Standards ,Current Procedural ,